Desmopressin Overdose with Water Intoxication
The most likely cause is desmopressin overdose leading to water intoxication and dilutional hyponatremia; immediately reduce the total daily dose to 0.2–0.3 mg/day and implement scheduled drug-free periods to allow breakthrough diuresis. 1
Pathophysiology of the Clinical Picture
- Polydipsia and salt cravings are physiologic responses to dilutional hyponatremia caused by excessive antidiuretic coverage that eliminates breakthrough diuresis in central diabetes insipidus. 1
- The current regimen of 0.5 mg/day (0.2 mg twice daily plus 0.1 mg at night) creates continuous 24-hour antidiuretic coverage, preventing the necessary periods of free water excretion. 1
- Chronic water retention develops when desmopressin dosing eliminates breakthrough diuresis, leading to mild-to-moderate hyponatremia that triggers compensatory salt cravings. 1
Immediate Diagnostic Steps
- Check serum sodium urgently—a low-normal value (135–138 mmol/L) or frankly low (<135 mmol/L) confirms desmopressin-induced water retention. 1
- Measure plasma osmolality; an inappropriately low value relative to the clinical picture supports the diagnosis. 1
- In central diabetes insipidus, serum sodium is normally maintained at steady state, so any deviation below 138 mmol/L indicates possible overdosing. 1
Dose Adjustment Protocol
Reduce Total Daily Dose
- Decrease desmopressin to 0.2–0.3 mg/day total, split into two doses (e.g., 0.1 mg morning and 0.1–0.2 mg evening), which fits within the standard therapeutic range of 0.2–0.4 mg/day for most central diabetes insipidus patients. 1, 2
- The morning and evening doses should be separately adjusted for an adequate diurnal rhythm of water turnover. 2
Implement Scheduled Drug Holidays
- Omit the nighttime dose and skip one morning or evening dose 1–2 times per week to allow breakthrough diuresis and prevent fluid intoxication. 1
- Planned desmopressin-free periods are essential to excrete accumulated free water. 1
Optimize Dosing Intervals
- Separate morning and evening doses by at least 8–12 hours; given desmopressin's terminal half-life of approximately 2.8 hours, this creates natural nadirs in antidiuretic effect. 1
- Administer oral tablets at least 1 hour before sleep, as maximum renal concentrating effect occurs after 1–2 hours. 3
Fluid Management Strategy
- Limit evening fluid intake to ≤200 mL and avoid drinking after the last dose until the following morning. 3, 1
- Allow unrestricted fluid intake during drug-free (breakthrough) periods to permit adequate diuresis. 1
- Polydipsia in the context of desmopressin overdose is a contraindication to further dosing and requires dose reduction, not dose escalation. 3, 1
Monitoring Plan
- Re-check serum sodium within 1 week of dose adjustment, then at 1 month and periodically thereafter to confirm correction. 1
- Intermittently track urine volume to verify adequate breakthrough diuresis is occurring. 1
- Monitor for resolution of salt cravings as hyponatremia corrects. 1
Critical Pitfall to Avoid
- Do not increase desmopressin in response to polydipsia—this is a recognized pitfall that exacerbates hyponatremia and water intoxication. 1
- The major complication of desmopressin therapy is water intoxication and hyponatremia, which can lead to seizures if unrecognized. 4
- Never maintain 24-hour antidiuretic coverage without planned breaks. 1